Concepedia

Bryann Pardieu

BP

6

Publications

286

Citations

6

H-Index

2020

Active since

Affiliations

Inserm(Current)

Hôpital Saint-Louis

Assistance Publique – Hôpitaux de Paris

Centre National de la Recherche Scientifique

Dana-Farber Cancer Institute

Bryann Pardieu is an author at Inserm specializing in drug discovery, medicine, and pharmacology.

ORCID

Top concepts

Publications per year

2020–2022

6

Publications

6

Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia

Bryann Pardieu, Justine Pasanisi, Frank Ling et al. · Leukemia · 2022 · 93 citations · Full text

, , +8

Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancer

Kevin Lin, Justine C. Rutter, Abigail Xie et al. · Nature Genetics · 2020 · 89 citations

, , +12

Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitor

Blandine Roux, Camille Vaganay, Jesse D. Vargas et al. · Science Translational Medicine · 2021 · 52 citations · Full text

The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting Therapies

Angela Su, Frank Ling, Camille Vaganay et al. · Cancer Discovery · 2020 · 24 citations · Full text

Screening of ETO2-GLIS2–induced Super Enhancers identifies targetable cooperative dependencies in acute megakaryoblastic leukemia

Salima Benbarche, Cécile K. Lopez, Eralda Salataj et al. · Science Advances · 2022 · 16 citations · Full text

Rows per page

1–5 of 6